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Microtubules are stiff filamentary proteins that constitute an important component of the cy-
toskeleton of cells. These are known to exhibit a dynamic instability. A steadily growing micro-
tubule can suddenly start depolymerizing very rapidly; this phenomenon is known as “catastrophe”.
However, often a shrinking microtubule is “rescued” and starts polymerizing again. Here we de-
velope a model for the polymerization-depolymerization dynamics of microtubules in the presence
of catastrophe-suppressing drugs. Solving the dynamical equations in the steady-state, we derive
exact analytical expressions for the length distributions of the microtubules tipped with drug-bound
tubulin subunits as well as those of the microtubules, in the growing and shrinking phases, tipped
with drug-free pure tubulin subunits. We also examine the stability of the steady-state solutions.
PACS numbers: 87.10.+e, 82.35.Pq, 87.15.Rn
I. INTRODUCTION
Microtubules are filamentary proteins and constitute
a major component of the cytoskeleton of the eukary-
otic cells [1, 2]. The dynamic cytoskeletal scaffolding
not only supports the cell architecture and gives rise
to changes in the shape of the cell but the network of
its constituent filamentary proteins also provides path-
ways for intra-cellular transport. In other words, a wide
range of dynamical processes, which are essential for
sustaining life, are driven by the dynamic cytoskeleton.
Therefore, a clear theoretical understanding of the fun-
damental physical principles behind the polymerization-
depolymerization dynamics of the microtubules is ex-
pected to provide deep insight into the physics of cell
shape transformations, cell motility, etc. as well as mech-
anisms of many sub-cellular processes like, for example,
chromosome segregations during mitosis (i.e., cell divi-
sion).
Dynamic instability [3, 4] is one of the unusual non-
equilibrium processes that dominate the dynamics of
microtubule polymerization. Each polymerizing mi-
crotubule persistently grows for a prolonged duration
and, then makes a sudden transition to a depolymeriz-
ing phase; this phenomenon is known as “catastrophe”.
However, the subsequent rapid shrinking of a depolymer-
izing microtubule can get arrested when it makes a sud-
den reverse transition, called “rescue”, to a polymerizing
phase. The elongation of a microtubule takes place by
a reversible, non-covalent attachment of a tubulin dimer
from the tubulin solution. It is now generally believed
that the dynamic instability of a microtubule is triggered
by the loss of its guanosine triphoshate (GTP) cap be-
cause of the hydrolysis of GTP into guanosine diphos-
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phate (GDP). But, the detailed mechanism, i.e., how the
chemical process of cap loss induces mechanical instabil-
ity, remains far from clear.
The dynamics of polymerization-depolymerization of
microtubules and the phenomena of ”catastrophe” and
”rescue” [5, 6, 7, 8], have been studied extensively
over the last decade using simple theoretical models
[9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21]. One of
the earliest models of polymerization-depolymerization
dynamics of microtubules was proposed by Hill [9] and
subsequently extended by Rubin and coworkers [10, 19].
The length of the microtubules is discrete in the Hill
model which is formulated in terms of two infinite sets
of coupled ordinary differential equations. Dogterom and
Leibler [11, 12], however, treated the length as a contin-
uous variable and the dynamical equations were reduced
to just two coupled partial differential equations.
A large number of different types of antimitotic
drug molecules are known to bind with free tubu-
lins in solution and/or with tubulins in microtubules.
The polymerization-depolymerization dynamics of mi-
crotubules, which play crucial roles in mitosis, is strongly
influenced by these drugs. The effects of various drug
molecules, e.g., colchicine, paclitaxel, vinca alkaloids and
taxol, etc., on the dynamics of microtubules have been
investigated experimentally for several years [22, 23, 24],
partly because of their potential clinical use in combating
cancer [25, 26, 27]. These drugs can be broadly classi-
fied into two groups. One group consists of microtubule-
destablizing agents whereas the members of the other
group are microtubule-stabilizing agents.
In this paper we are interested in the effects
of microtubule-stabilizing agents (i.e., catastrophe-
suppressing drugs) on the length distributions of the mi-
crotubules in the absence of any GTP and GDP in the
system. The generic drug molecules of our interest are
assumed to bind rapidly with free tubulins in solution;
when such a tubulin-drug complex binds with the grow-
ing end of a microtubule, the drug-capped microtubule
2gets stabilized because of the strong suppression of catas-
trophe phenomenon [26, 27].
Recall that there are four main rate constants
(or, frequencies) that characterize the four impor-
tant processes involved in microtubule polymeriza-
tion/depolymerization dynamics. Two of these are the
rate constants for the attachment and detachment of
tubulin dimers in the polymerization and depolymeriza-
tion phases, respectively while the remaining two are
the frequencies of catastrophe and rescue. We assume
that the generic drug has the following two effects on the
polymerization dynamics: (i) it reduces the frequency of
catastrophe to such a large extent that the microtubules
capped with drug-bound tubulins do not exhibit catas-
trophe at all, and (ii) it also affects the rate of elongation
of the microtubules because the rate constant for the at-
tachment of a drug-bound tubulin is, in general, differ-
ent from that of a drug-free tubulin. The effects of real
catastrophe-suppressing drugs are quite complicated and
depend also on the dosage of the drug; some even induce
a “paused” phase [26].
The aim of this paper is to investigate theoretically
the generic effects of catastrophe-suppressing drugs by ex-
tending the earlier theoretical models, developed by Hill
[9] and Freed [20], for the dynamics of polymerization of
drug-free pure tubulins. We derive exact analytical ex-
pressions for the steady-state distributions of the lengths
of the microtubules tipped with the drug-bound tubu-
lin subunits as well as those of microtubules tipped with
pure (i.e., drug-free) tubulin subunits. We carry out lin-
ear stability analysis of the steady-state distributions and
physically interpret the implications of the spectrum of
the eigenvalues of the stability matrix.
This paper is organized as follows. In section II we
briefly review some of the relevant earlier theoretical
models of dynamic instability. In paricular, we sum-
marize the mathematical frameworks of the Hill model
[9] and the recent Freed model [20] of dynamic insta-
bility of microtubules. In section III we propose an ex-
tension of the Hill model so as to capture the effects of
the catastrophe-suppressing drugs in a simple way. The
model is made more realistic in section IV by treating
the dynamics of the concentration of the drug-free tubu-
lins explicitly following a Freed-like approach. The paper
ends with a conclusion section V.
II. BRIEF REVIEW OF EARLIER MODELS OF
DYNAMIC INSTABILITY
A. Hill model
Microtubules consist of 13 protofilaments, each con-
sisting of monomeric units (actually a α − β hetero-
dimer) each of which is approximately 8 nm long. On
the other hand, the polymers in the Hill model are one-
dimensional. Therefore, some authors (see, for example,
[28]) identify “monomeric units” of the one-dimensional
Hill model to have a length of approximately 8/13 = 0.6
nm.
Let P+H (n, t) and P
−
H (n, t) be the probabilities of find-
ing a microtubule of length n, at time t, in the growing
(+) and shrinking (−) phases, respectively. Moreover, let
PH(0, t) be the probability that the MT nucleating site
is empty at time t. Furthermore, we denote the growth
rate of the growing microtubules and decay rate of the
shrinking microtubules by pHg and p
H
d , respectively, while
the frequencies of catastrophes (the transition from grow-
ing to the shrinking phase) and rescues (the transition
from the shrinking to growing phase) are denoted by the
symbols pH+− and p
H
−+, respectively. Interestingly, the
four parameters pHg , p
H
d , p
H
+− and p
H
−+ were measured
as functions of free tubulin concentration first in 1988
[29] by observing single microtubules using video light
microscopy. However, the concentration dependence of
these parameters, if any, does not appear explicitly in
the Hill model.
The Master equations for these probabilities are given
by [9]
dP+H (n, t)
dt
= pHg P
+
H (n− 1, t) + p
H
−+P
−
H (n, t)−
(pHg + p
H
+−)P
+
H (n, t), for n ≥ 2, (1)
dP−H (n, t)
dt
= pHd P
−
H (n+ 1, t) + p
H
+−P
+
H (n, t)−
(pHd + p
H
−+)P
−
H (n, t), for n ≥ 1, (2)
dP+H (1, t)
dt
= pHg PH(0, t)+p
H
−+P
−
H (1, t)−(p
H
g +p
H
+−)P
+
H (1, t),
(3)
and
dPH(0, t)
dt
= −pHg PH(0, t) + p
H
d P
−
H (1, t). (4)
Imposing the normalization
∞∑
n=1
P+H (n) +
∞∑
n=1
P−H (n) + PH(0) = 1, (5)
the steady-state solutions of the equations (1)-(4) are
given by [9]
P+H (n) = x
n
HPH(0), (6)
and
P−H (n) = x
n−1
H yHPH(0) (7)
with
PH(0) =
1− xH
1 + yH
, (8)
xH =
pHg (p
H
d + p
H
−+)
pHd (p
H
g + p
H
+−)
(9)
3and
yH =
pHg
pHd
. (10)
In order that the distributions P±H (n) are decreasing,
rather than increasing, functions of n we must have xH <
1 which imposes the constraint pHg (p
H
d +p
H
−+) < p
H
d (p
H
g +
pH+−), i.e.,
pHg p
H
−+ < p
H
d p
H
+− (11)
on the magnitudes of the parameters. Interestingly, in
the Dogterom- Leibler model [11], a steady-state charac-
terized by exponentially decaying distributions P± of the
lengths of the microtubules is attained only if the con-
dition (11) is satisfied by the parameters; otherwise, the
system never reaches any steady-state and mean of the
(Gaussian) distribution of the lengths of the microtubules
continues to increase linearly with time.
B. Freed model
It has been realized for quite some time [16, 17, 29] that
the rate of growth of the growing microtubules should de-
pend on the availability of free tubulin monomers in the
solution. However, in the Hill model [9] the kinetic rate
equations do not involve the concentration of the tubulin
monomers. Recently, Freed [20] has generalized the Hill
model to incorporate the dependence of the rates on the
tubulin monomer concentration. Hammele and Zimmer-
mann [21] carried out independent analytical calculations
of the same phenomenon by extending the Dogterom-
Leibler [11] model. Since our calculations in the section
IV are based on an extension of Freed’s model, we sum-
marize here the main points of this approach.
Suppose, ρ0 is the initial concentration of the tubulin
subunits and ρ is the corresponding instantaneous con-
centration at time t. Similarly, N0 and N are the initial
and instantaneous concentrations of the free (i.e., with-
out bound tubulin) nucleating sites, respectively. The
symbols P±F (n, t) in this section denote the concentra-
tions, rather than probabilities, of microtubules in the
growing and the shrinking phases, respectively. More-
over, binding of a tubulin subunit with a free nucleating
site takes place at a rate pFn . Using these quantities, the
kinetic rate equations in the Freed model [20] can now
be written as
dP+F (n, t)
dt
= pFg ρP
+
F (n− 1, t) + p
F
−+P
−
F (n, t)−
(pFg ρ+ p
F
+−)P
+
F (n, t), for n ≥ 2, (12)
dP−F (n, t)
dt
= pFd P
−
F (n+ 1, t) + p
F
+−P
+
F (n, t)−
(pFd + p
F
−+)P
−
F (n, t), for n ≥ 1, (13)
dP+F (1, t)
dt
= pFn ρN+p
F
−+P
−
F (1, t)−(p
F
g ρ+p
F
+−)P
+
F (1, t),
(14)
and
dρ
dt
= −pFn ρN−p
F
g ρ
∞∑
n=1
P+F (n, t)+p
F
d
∞∑
n=1
P−F (n, t). (15)
Moreover, tubulin mass conservation imposes the condi-
tion
ρ0 = ρ+Q
+
F +Q
−
F (16)
where
Q±F =
∞∑
n=1
nP±F (n, t). (17)
Furthermore,
N0 = N + P
+
F + P
−
F (18)
where
P±F =
∞∑
n=1
P±F (n, t). (19)
There is one-to-one correspondence between the pa-
rameters and dynamical variables in the Freed model and
those in the Hill model. For example, pFg ρ, p
F
d , p
F
+− and
pF−+ correspond to p
H
g , p
H
d , p
H
+− and p
H
−+, respectively.
The steady-state solution of this system of kinetic
equations is given by [30]
P+F = p
F
nN0ρ(p
F
−+ + p
F
d )/D (20)
P−F = p
F
nN0ρ(p
F
+− + p
F
g ρ)/D (21)
and
P−F (1) = β
′ = pFnN0ρ(p
F
d p
F
+− − p
F
g ρp
F
−+)/(p
F
d D) (22)
where
D = pFn p
F
g ρ
2+(pFd p
F
n+p
F
n p+−−p
F
g p
F
−+)ρ+(p
F
d p
F
+−+p
F
n ρp
F
−+).
(23)
Finally, using a generating function technique, Freed[20]
derived the analytical expressions
P+F (n) = (a
′c′)(n−1)/2[(f ′ + β′d′)Un−1(λ
′)
−(a′c′)−1/2a′f ′Un−2(λ
′)] (24)
and
P−F (n) = (a
′c′)(n−1)/2[β′Un−1(λ
′)
+(a′c′)−1/2(b′f ′ − c′β′)Un−2(λ
′)] for n ≥ 2, (25)
where
a′ = (pFd + p
F
−+)/p
F
d , (26)
4b′ = −pF+−/p
F
d , (27)
c′ = pFg ρ/(p
F
g ρ+ p
F
+−), (28)
d′ = pF−+/(p
F
g ρ+ p
F
+−), (29)
f ′ = pFn ρN/(p
F
g ρ+ p
F
+−). (30)
λ′ = (a′ + b′d′ + c′)/[2(a′c′)1/2] (31)
and Un(λ
′) are the Chebyshev polynomial of the second
kind given by
Un(λ
′) = sin[(n+ 1) arccosλ′]/(1− λ′2)1/2, (32)
together with U−1(λ
′) = 0.
The distributions P±F (n) will be decreasing functions
of n provided the condition a′c′ < 1 is satisfied; this
condition imposes the constraint
pFg ρp
F
−+ < p
F
d p
F
+− (33)
on the magnitudes of the parameters and the value of
the drug-free tubulin subunits ρ in the steady-state. The
condition (33) becomes identical to (11) if we identify
pFg ρ with p
H
g .
While expressing the steady-state distributions P±F (n)
in terms of Chebyshev polynomial, Freed [20] implicitly
assumed that |λ′| < 1. However, as shown in appendix A,
λ′ is, in general, larger than unity. We revise the Freed’s
result in section IV by taking λ′ ≥ 1 and, consequently,
we get a different polynomial instead of the Chebyshev
polynomial given in (32).
Freed [20] derived the exact form of the stability ma-
trix. we define
∆± =
∞∑
n=1
δP±(n) (34)
and the column vectors
V(t) =

 ∆+∆−
δρ

 (35)
NF =

 0−pd
0

 (36)
The, the equations obtained from the linear stability
analysis above can be written as
dV(t)
dt
= MFV(t) +NFδP
F
− (1) (37)
where the matrix MF is given by
MF =

 −p+− − pn[ρ]ss p−+ − pn[ρ]ss M13p+− −p−+ 0
(pn − pg)[ρ]ss pn[ρ]ss + pd M33

 (38)
with
M13 = pn{N0 − [P+]ss − [P−]ss} (39)
and
M33 = (pn − pg)[P+]ss − pn(N0 − [P−]ss) (40)
The nature of the stability of the steady-state is deter-
mined by the eigenvalues of the matrix MF. The steady
state is stable if all the eigenvalues are real and nega-
tive. On the other hand, if some roots are positive, these
would indicate unbounded growth and the correspond-
ing steady-state would be unstable. If the characteristic
equation has a pair of complex conjugate roots then the
system will either oscillate about the steady state (if the
real part is negative) or exhibit oscillatory unbounded
growth (if the real part is positive).
We have carried out numerical analysis of this stability
matrix and obtained the eigenvalues for several sets
of values of the model parameters; the eigenvalues
corresponding to five different values of ρ, for a fixed
set of values of the other model parameters, are shown
in the table I. Thus, the steady-state distribution is
stable over the entire range of ρ for the chosen set of
parameters values.
III. HILL-LIKE MODEL WITH DRUGS
Let phc be the rate of growth of a microtubule by
addition of a drug-bound tubulin. Since addition of
catastrophe-suppressing drugs to the system strongly re-
duce the catastrophe frequency, we assume that the drug
5ρ m1 m2 m3
0.4 -49.984 -0.282 -23.719
0.8 -99.999 -0.295 -22.507
1.6 -199.999 -0.299 -20.456
2.0 -250.000 -0.299 -19.566
2.5 -312.500 -0.300 -18.577
TABLE I: The eigenvalues of the linear stability matrix MF
in the Freed model. The other common parameters for above
table are pg = 125, pd = 900, p−+ = 0.08, p+− = 0.22, N0 =
0.2 (in respective units).
is such that it arrests catastrophe. In other words, a
microtubule tipped with a drug-bound tubulin can grow
but cannot shrink. We shall use the symbol Πh(n, t) to
denote the probability of a microtubule, tipped with a
drug-bound tubulin, that has length n at time t. As a
consequence of our assumption, we do not need to con-
sider the two quantities Π+h (n, t) and Π
−
h (n, t) separately;
Π−h (n, t) = 0 for all n at all t. However, even in the
presence of such drugs in the system, catastrophes can
take place in microtubules tipped with drug-free tubu-
lins. The distributions of the microtubules tipped with
drug-free tubulin subunits in the growing and shrinking
phases are denoted by P+h (n, t) P
−
h (n, t), respectively.
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FIG. 1: A schematic description of our Hill-like model in the
presence of catastrophe-suppressing drugs. The superscript
h has been dropped from the symbols denoting the model
parameters.
Thus, the equations (1)-(4) are generalized to the forms
dP+h (n, t)
dt
= phg [P
+
h (n− 1, t) + Πh(n− 1, t)] + p
h
−+P
−
h (n, t)
− (phg + p
h
c + p
h
+−)P
+
h (n, t), for n ≥ 2,
(41)
dP−h (n, t)
dt
= phdP
−
h (n+ 1, t) + p
h
+−P
+
h (n, t)
−(phd + p
h
−+)P
−
h (n, t), for n ≥ 1, (42)
dP+h (1, t)
dt
= phgPh(0, t)+p
h
−+P
−
h (1, t)−(p
h
g+p
h
c+p
h
+−)P
+
h (1, t),
(43)
dPh(0, t)
dt
= −(phg + p
h
c )Ph(0, t) + p
h
dP
−
h (1, t), (44)
dΠh(n, t)
dt
= phc [Πh(n− 1, t) + P
+
h (n− 1, t)]
− (phg + p
h
c )Πh(n, t), for n ≥ 2,
(45)
dΠh(1, t)
dt
= phcPh(0, t)− (p
h
g + p
h
c )Πh(1, t). (46)
In order to distinguish between the Hill model and our
Hill-like model with catastrophe-suppressing drugs, we
replace the subscripts (and superscripts) H of the former
by h in the latter.
The steady-state solutions of these kinetic equations
(see appendix B for details) are
P+h (n) = xh(xh + zh)
n−1Ph(0), (47)
P−h (n) = yh(xh + zh)
n−1Ph(0), (48)
Πh(n) = zh(xh + zh)
n−1Ph(0), (49)
where
Ph(0) =
1− xh − zh
1 + yh
(50)
with
xh =
phg (p
h
d + p
h
−+) + p
h
cp
h
−+
phd(p
h
g + p
h
+−) + p
h
cp
h
d
(51)
and
yh =
phg + p
h
c
phd
(52)
zh =
phc
phc + p
h
g
(53)
The distributions (51-53) are decreasing functions of n
provided (xh + zh) < 1, i.e,
(phg + p
h
c )
2 ph−+ < p
h
g p
h
d p
h
+− (54)
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FIG. 2: The steady-state distributions (a) P+h (n), (b) P
−
h (n)
and (c) Πh(n) of the size n of microtubules in our Hill-like
model in the presence of catastrophe-suppressing drugs are
plotted for several values of phc ; the common parameters are
phg = 0.5, p
h
d = 0.75, p
h
+− = 0.01 and p
h
−+ = 0.01, each per
unit time.
this condition (54) reduces to the condition (11) in the
limit phc → 0. Note that in the limit p
h
c → 0, zh → 0
while the expressions (51) and (52) for xh and yh re-
duce to xH and yH given by the expressions (9) and
(10), respectively; hence, in this limit, Πh(n) → 0 and
the expressions (47) and (48) for P±h (n) reduce to the
corresponding expressions (6) and (7) for P±H (n).
The parameters phg , p
h
d , p
h
+−, p
h
−+, etc. have dimensions
[time−1]. For a typical set of values of these param-
eters, we have plotted the distributions P+h (n), P
−
h (n)
and Πh(n) in fig.2(a),(b) and (c), respectively, each for
several different numerical values of phc . The straight
lines on the semi-log plots is a reflection of the expo-
nential decay of the distribution with increasing length
of the microtubules. Moreover, the longer tails of these
distributions at at higher values of phc demonstrates that
higher phc causes stronger suppression of the catastrophe
phenomenon.
A. Stability of the steady-state
Let us define the small deviations
δP±h (n) = P
±
h (n, t)− [P
±
h ]ss (55)
δΠh(n) = Πh(n, t)− [Πh]ss (56)
from the corresponding steady-states where the steady-
state values [P±]ss and [Π]ss are given by the equations
(47), (48) and (49), respectively. Linear stability analysis
of the steady-state distributions leads to the equations
dδP+h (n, t)
dt
= phg [δP
+
h (n− 1, t) + δΠh(n− 1, t)]
+(phg + p
h
c + p
h
+−)δP
+
h (n, t) for n ≥ 2 (57)
dδP−h (n, t)
dt
= phdδP
−
h (n+ 1, t) + p
h
+−δP
+
h (n, t)
−(phd + p
h
−+)δP
−
h (n, t)
for n ≥ 1 (58)
dδΠh(n, t)
dt
= phc {δΠh(n− 1, t) + δP
+
h (n− 1, t)}
−(phg + p
h
c )δΠh(n, t)for n ≥ 2 (59)
dδP+h (1, t)
dt
= phgδP (0, t) + p
h
−+δP
−
h (1, t)
−(phg + p
h
c + p
h
+−)δP
+
h (1, t) (60)
dδΠh(1, t)
dt
= phc δP (0, t)− (p
h
g + p
h
c )δΠh(1, t)}
(61)
Using the normalization condition we get
δP (0, t) = −
∞∑
n=1
δP+h (n, t)−
∞∑
n=1
δP−h (n, t)−
∞∑
n=1
δΠh(n, t)
(62)
7Next, we define
∆± =
∞∑
n=1
δP±h (n) (63)
∆0 =
∞∑
n=1
δΠh(n) (64)
and the column vectors
W(t) =

 ∆+∆−
∆0

 (65)
Nh =

 0−phd
0

 (66)
The equations obtained from the linear stability analysis
above can be written as
dW(t)
dt
= MhW(t) +NhδP
−
h (1, t) (67)
where the matrix Mh is given by
Mh =

 −(p
h
c + p
h
+− − p
h
g ) p
h
−+ − p
h
g 0
ph+− −p
h
−+ 0
0 −pc −(p
h
g + p
h
c )

 (68)
phc m1 m2 m3
0 -100.000 -100.000 -0.300
10 -100.020 -100.000 -0.280
20 -120.037 -120.000 -0.263
30 -130.051 -130.000 -0.249
50 -150.073 -150.000 -0.227
100 -200.110 -200.000 -0.190
150 -250.132 -250.000 -0.168
TABLE II: The eigenvalues of the linear stability matrix Mh
in our Hill-like model. The common parameters are phg =
100, phd = 900, p
h
−+ = 0.08, p
h
+− = 0.22, (each per unit time)
.
Note that all the eigenvalues remain negative up to a
reasonably high value of pc corresponding to the param-
eter set chosen for the table II. This result indicates that
the steady state distributions of the lengths of the mi-
crotubules, which we have derived in this section, remain
stable up to a moderately high dosage of the catastrophe
suppressing drug.
IV. EFFECTS OF DRUGS ON MT: A HYBRID
HILL-FREED-LIKE MODEL
In this section we extend the Hill-like model developed
in section III by taking into account the dependence of
the rate of growth of the microtubules on the concen-
tration of the drug-free tubulin subunits in the solution;
for this purpose we follow the corresponding approach
developed by Freed (and reviewed in section II) for mi-
crotubule dynamics in the absence of drugs. However,
the effects of the drug-bound tubulin subunits are taken
into account in the same way as was done in the Hill-like
model presented in the section III. Therefore, the model
presented in this section is a hybrid of Hill-like and Freed-
like approaches; the drug-free tubulins are treated fol-
lowing Freed while the drug-bound tubulins are treated
following Hill.
The binding of a drug-bound tubulin subunit with a
free nucleating site takes place with probability pnc per
unit time. Following Freed, the concentration of micro-
tubules of length n which are tipped with drug-bound
tubulin subunits is denoted by the symbol Π(n, t) while
that of the microtubules tipped with drug-free tubulin
subunits and in the growing (shrinking) phase is denoted
by P+(n, t) (P−(n, t)). Moreover, all the parameters with
identical susbcripts in this model and in the Freed model
have the same physical significance. The equations of our
interest are
dP+(n, t)
dt
= pgρ[P+(n− 1, t) + Π(n− 1, t)] + p−+P−(n, t)
−(pgρ+ pc + p+−)P+(n, t) for n ≥ 2,(69)
dP−(n, t)
dt
= pdP−(n+ 1, t) + p+−P+(n, t)
−(pd + p−+)P−(n, t) for n ≥ 1, (70)
dΠ(n, t)
dt
= pc[Π(n− 1, t) + P+(n− 1, t)]
−(pgρ+ pc)Π(n, t) for n ≥ 2, (71)
dP+(1, t)
dt
= pnρN + p−+P−(1, t)
−(pgρ+ pc + p+−)P+(1, t), (72)
dΠ(1, t)
dt
= pncN − (pgρ+ pc)Π(1, t), (73)
8and
dρ
dt
= −pnρN−pgρ
∞∑
n=1
[P+(n, t)+Π(n, t)]+pd
∞∑
n=1
P−(n, t).
(74)
The steady state equations are
pnρ(N0 − P+ − P− −Π) = −pgρ(P+ +Π) + pdP−,(75)
P+(n) = cP+(n− 1) + dP−(n) + cΠ(n− 1), (76)
P−(n) = aP−(n− 1) + bP+(n− 1), (77)
Π(n) = eΠ(n− 1) + eP+(n− 1), (78)
P+(1) = dP−(1) + f, (79)
Π(1) = g, (80)
where
a = (pd + p−+)/pd, (81)
b = −p+−/pd, (82)
c = pgρ/(pgρ+ pc + p+−), (83)
d = p−+/(pgρ+ pc + p+−), (84)
e = pc/(pgρ+ pc), (85)
f = pnρN/(pgρ+ pc + p+−), (86)
and
g = pncN/(pgρ+ pc). (87)
Note that in the limit of vanishing concentration of drug-
bound tubulin, i.e., pc → 0, the expressions (81)- (84)
for a, b, c, and d reduce to the expressions (26)-(29) for
a′, b′, c′ and d′, respectively. Moreover, in the limit
pc → 0 and pnc → 0, equations (85) and (87) imply
e → 0 and g → 0 while the expression (86) reduces to
the corresponding expression (30) of the original Freed
model.
Defining
P+ =
∞∑
n=1
P+(n),
P− =
∞∑
n=1
P−(n),
Π =
∞∑
n=1
Π(n), (88)
we obtain the following three equations from (77), (76)
and (78),
(1− a)P− − bP+ = P−(1), (89)
(1− c)P+ − cΠ− dP− = f, (90)
(1− e)Π− eP+ = Π(1), (91)
We solve for P+, P− and Π using (90), (91) and (75).
Substituting these solutions in (89), we obtain P−(1) at
the steady state. Finally, steady state expressions for
P+(1) and Π(1) are obtained from (79) and (80).
The solutions of linear equations (90), (91) and (75)
can be obtained in a straightforward way. The solutions
are
P+ =
ρN0pgp2(ρpn + pnc)
D
, (92)
P− =
ρN0pg(ρpn + pnc)(p1 + ρpg)
D
, (93)
Π =
N0[ρpcpnp2 − ρpgp−+pnc + pdpncp1]
D
, (94)
P−(1) =
ρN0pg(ρpn + pnc)(p+−pd − pcp−+ − ρp−+pg)
(pdD)
,
(95)
where
D = ρ3p2gpn + pdpncp1 + ρ
2p2g(pnc − p−+)
+ρ2pgpn(p1 + p2) + ρpcp2pn + ρpgpc(pnc − p−+)
+ρpgpncp+− + ρpgpd(pnc + p+−), (96)
with
p1 = pc + p+− (97)
and
p2 = pd + p−+. (98)
In the following the generating function method is used
to obtain the P+(n), P−(n) and Π(n) for arbitrary n. We
proceed by multiplying both sides of equations (76), (77)
and (78) by xn and then suming over n from n = 1 to
∞. Defining
P+(x) =
∞∑
n=1
P+(n)x
n, (99)
P−(x) =
∞∑
n=1
P−(n)x
n (100)
and
Π(x) =
∞∑
n=1
Π(n)xn, (101)
9we have the following equations for P+(x), P−(x) and
Π(x):
(1− cx)P+(x)− dP−(x)− cxΠ(x) = xf (102)
bxP+(x) + (ax− 1)P−(x) = −xβ (103)
exP+(x) + (ex− 1)Π(x) = −xg (104)
where β = P−(1). Solving this set of linear equations for
P+(x), P−(x) and Π(x), we find
P+(x) =
(aef − acg)x3 − (βde − cg + ef + af)x2 + (βd+ f)x
∆
,
(105)
P−(x) =
(bcg − bef)x3 + (bf − βc− βe)x2 + βx
∆
,
(106)
Π(x) =
(acg − aef)x3 + (βde − cg + ef − ag − bdg)x2 + gx
∆
.
(107)
where
∆ = (ac+ ae+ bde)x2 − (a+ c+ e + bd)x+ 1. (108)
P+(x) =
(aef − acg)x3 − (βde − cg + ef + af)x2 + (βd+ f)x
y2 − 2λy + 1
,
(109)
P−(x) =
(bcg − bef)x3 + (bf − βc− βe)x2 + βx
y2 − 2λy + 1
,
(110)
Π(x) =
(acg − aef)x3 + (βde − cg + ef − ag − bdg)x2 + gx
y2 − 2λy + 1
.
(111)
where
λ = (a+ e+ c+ bd)/[2(ac+ ae+ bde)1/2]. (112)
and
y = (a+ e + c+ bd)1/2x. (113)
Solutions for P±(n) and Π(n) can be obtained by ex-
panding term
1
y2 − 2λy + 1
(114)
in the above equations using Taylor series expansion for
λ ≥ 1 and y < 1 and then equating the coefficients of yn
on both sides. Thus, the expressions for P±(n) and Π(n)
are as follows:
P+(n) = α
(n−1)/2[α3Un−1(λ) − α2Un−2(λ) + α1Un−3(λ)]
for n ≥ 2,
(115)
P+(1) = α3U0(λ) (116)
where
α = (ac+ ae+ bde), (117)
α1 = (aef − acg)/α, (118)
α2 = (βde − cg + ef + af)/α
1/2, (119)
α3 = (βd+ f), (120)
and
Un(λ) =
[n/2]∑
m=0
(−1)m
(n−m)!
m!(n− 2m)!
(2λ)n−2m, (121)
with U−1(λ) = 0, where the symbol [n/2] represents the
largest integer smaller than or equal to n/2. Similarly,
P−(n) = α
(n−1)/2[βUn−1(λ) + β2Un−2(λ) + β1Un−3(λ)]
for n ≥ 2,
(122)
P−(1) = βU0(λ) (123)
where
β1 = (bcg − bef))/α (124)
β2 = (bf − βc− βe)/α
1/2. (125)
Finally,
Π(n) = α(n−1)/2[gUn−1(λ) + γ2Un−2(λ) + γ1Un−3(λ)],
(126)
Π(1) = gU0(λ) (127)
where
γ1 = (acg − aef)/α, (128)
γ2 = (βde − cg + ef − ag − bdg)/α
1/2. (129)
It can be easily checked that these solutions approach
Freed’s solutions in the limit pnc → 0, pc → 0. In or-
der that the steady state solutions for P+(n), P−(n) and
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FIG. 3: The steady-state length distributions (a) P+(n), (b)
P−(n) and (c) Π(n) of microtubules in our hybrid model for
several values of pc and compared with corresponding distri-
butions in our Hill-like model (with appropriate rescaling of
the parameters and variables following (131); the common
parameters are pg = pn = 125, pd = 900, p−+ = 0.08,
p+− = 0.22, pnc = pc, and ρ = 0.8, N0 = 0.2 (in respec-
tive units).
Π(n) are decreasing, rather than increasing, functions of
n, we demand that α < 1 which imposes the following
constraint on the magnitudes of the parameters:
p−+(pc + ρpg)
2 < ρpgpdp+− (130)
The condition (130) reduces to the corresponding condi-
tion (33) of the Freed model in the limit pc → 0.
In order to plot the steady-state distributions (115),
(122) and (126) in our hybrid Hill-Freed-like model and
to compare these with the distributions (47), (48) and
(49) for the same set of parameters, we first converted
the concentrations of the different types of microtubules
into probabilities and, then, chose the numerical values
of the parameters so as to satisfy the following relations:
phg = pgρ,
phd = pd,
phc = pc,
ph+− = p+−,
ph−+ = p−+. (131)
The distributions plotted in fig.3 shows that with proper
rescaling of the parameters, as mentioned in (131), the re-
sults for the Hill-like model and the hybrid Hill-Freed-like
model are almost identical. Moreover, the higher is the
value of pc, the longer are the tails of the distributions;
this, as explained already in the context of the Hill-like
model, is a consequence of the stronger suppression of
the catastrophes by higher pc.
The mean lengths of the microtubules, which corre-
spond to the distributions plotted in the fig.3, are plotted
against pc in fig.4. Surprisingly, for this set of parame-
ter values the mean lengths of the microtubules tipped
with drug-bound tubulin and those tipped with drug-free
tubulins (both in the growing and shrinking phases) are
identical for almost all values of pc. However, even for
this set of parameters values, the fraction of microtubules
with drug-bound cap increases with increasing pc while
that with drug-free cap decreases (see fig.5).
We now define the “effective” catastrophe frequency
and the “effective” rescue frequency by the relations
peff+− =
p+−P+
P+ + P− +Π
=
p+−P+
1− P0
(132)
and
peff−+ =
p−+P−
P+ + P− +Π
=
p−+P−
1− P0
(133)
These “effective” frequencies of catastrophe and rescue
are plotted against pc in fig.6. This trend of variation
is qualitatively similar to the corresponding results of
laboratory experiments performed with the catastrophe-
supprssing drug vinblastine [31].
A. Stability of the steady-state
We have obtained the exact analytical expressions for
the matrices that decide the stability of the steady-state
solutions, which we derived earlier in this section, against
small deviations. For this purpose we expand the nonlin-
ear kinetic equations about the steady states and retain
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FIG. 4: Mean length of the microtubules in the hybrid model.
The numerical values of all the parameters, which are not
shown explicitly, are identical to those in fig.3.
only upto the terms linear in the deviations and drop all
the terms containing higher orders of deviations.
Let us define the small deviations
δρ = ρ(t)− [ρ]ss, (134)
δP±(n) = P±(n, t)− [P±]ss (135)
δΠ(n) = Π(n, t)− [Π]ss (136)
from the corresponding steady-states where the steady-
state values [P±]ss, [Π]ss, etc. are given by the equations
(115), (116), (122), (123), (126), (127), etc. We shall
also use the symbols [P+]ss, [P−]ss and [Φ]ss to denote
the steady-state values of P+, P− and Π given by the
equations (88).
Expanding the equations (69)- (74) about the steady
state and retaining upto the terms linear in the small
deviations we get
dδP+(n)
dt
= pgδρ{[P+(n− 1)]ss + [Π(n− 1)]ss}
+pg[ρ]ss{δP+(n− 1) + δΠ(n− 1)}+ p−+δP−(n)
−pgδρ[P+(n)]ss − pg[ρ]ssδP+(n)
−(pc + p+−)δP+(n) for n ≥ 2(137)
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FIG. 5: Fractions of the microtubules that are tipped with
drug-free tubulin and are in the growing phase (P+) or in
the shrinking phase (P−) and those of microtubules tipped
with durg-bound tubulin (Π). The numerical values of all the
parameters, which are not shown explicitly, are identical to
those in the fig.3.
dδP−(n)
dt
= pdδP−(n+ 1) + p+−δP+(n)
−(pd + p−+)δP−(n)
for n ≥ 1 (138)
dδΠ(n)
dt
= pc{δΠ(n− 1) + δP+(n− 1)}
−pg[ρ]ssδΠ(n)− pgδρ[Π(n)]ss − pcδΠ(n)
for n ≥ 2 (139)
dδP+(1)
dt
= pnτ + p−+δP−(1)
−pg{[ρ]ssδP+(1) + δρ[P+(1)]ss}
−(pc + p+−)δP+(1) (140)
dδΠ(1)
dt
= pnc{−
∞∑
n=1
δP+(n)−
∞∑
n=1
δP−(n)−
∞∑
n=1
δΠ(n)}
−pg{[ρ]ssδΠ(1) + δρ[Π(1)]ss} − pcδΠ(1)
(141)
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FIG. 6: Effective catastrophe frequency (a) and effective res-
cue frequency (b), defined through equations (132) and (133),
respectively, are plotted against pc for ρ = 2.0. Note the dif-
ferent parameters used for the insets. The numerical values of
all the parameters, which are not shown explicitly, are iden-
tical to those in the fig.3.
dδρ
dt
= −pnτ − pgδρ{
∞∑
n=1
[P+(n)]ss +
∞∑
n=1
[Π(n)]ss}
−pg[ρ]ss{
∞∑
n=1
δP+(n) +
∞∑
n=1
δΠ(n)}
+pd
∞∑
n=1
δP−(n)(142)
where
τ = δρ{N0 − [P+]ss − [P−]ss − [Φ]ss}
+[ρ]ss{−
∞∑
n=1
δP+(n)−
∞∑
n=1
δP−(n)−
∞∑
n=1
δΠ(n)}
(143)
Next, we define
∆± =
∞∑
n=1
δP±(n) (144)
∆0 =
∞∑
n=1
δΠ(n) (145)
and the column vectors
V(t) =


∆+
∆−
∆0
δρ

 (146)
N =


0
−pd
0
0

 (147)
The equations obtained from the linear stability analysis
above can be written as
dV(t)
dt
= MV(t) +NδP−(1) (148)
where the matrix M is given by
M =


−(pc + p+−)− pn[ρ]ss p−+ − pn[ρ]ss (pg − pn)[ρ]ss M14
p+− −p−+ 0 0
pc − pnc −pnc −pg[ρ]ss − pnc −pg[Φ]ss
(pn − pg)[ρ]ss pn[ρ]ss + pd (pn − pg)[ρ]ss M44

 (149)
where
M14 = pg[Φ]ss+pn{N0− [P+]ss− [P−]ss− [Φ]ss} (150)
M44 = (pn−pg)([P+]ss+[Φ]ss)−pn(N0− [P−]ss) (151)
The characteristic equation is quartic in the eigenvalue
λ. We have systematically investigated the trend of vari-
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ρ = 0.8M
pc m1 m2 m3 m4
0 -99.998 -0.295 -22.506 -100.000
5 -105.000 -0.185 -22.633 -104.982
10 -110.000 -0.094 -22.734 -109.972
15 -115.000 -0.019 -22.814 -114.967
16 -116.000 -0.005 -22.828 -115.967
17 -117.000 0.008 -22.842 -116.966
ρ = 2.0M
pc m1 m2 m3 m4
0 -249.999 -0.299 -19.566 -250.000
50 -300.000 -0.121 -19.717 -300.023
100 -350.000 -0.030 -19.785 -350.051
126 -376.000 -0.001 -19.803 -376.061
127 -377.000 0.002 -19.804 -377.062
TABLE III: The eigenvalues of the linear stability matrix M.
The common parameters are pg = pn = 125, pd = 900, p−+ =
0.08, p+− = 0.22, pnc = pc, N0 = 0.2 (in respective units).
ation of the eigenvalues (m1,m2,m3,m4) of the matrix
M with the variation of pc for several sets of values
of the other parameters; those for two values of ρ are
given in table III. In both these cases, there is a range
0 ≤ pc ≤ p
max
c of values of pc where all the eigenvalues
remain negative indicating stability of the steady state.
Moreover, the higher is the steady-state density ρ of the
free tubulins in the solution larger is the value of pmaxc .
As pc is incresed beyond p
max
c , one of the negative eigen-
values simply changes sign which indicates instability of
the steady-state. The physical reason for the instabil-
ity of the steady state at sufficiently high pc is that the
higher is the pc the larger is the fraction of microtubules
tipped with drug-bound tubulin which can only grow but
cannot shrink.
Thus, although the steady-state distributions of the
microtubules in the Hill-like model and those in the hy-
brid Hill-Freed-like model can be made practically identi-
cal by making appropriate correspondence of the param-
eters in the two models, the latter has a richer dynamics
which is reflected also in the linear stability analysis.
V. SUMMARY AND CONCLUSION
In this paper we have developed models for study-
ing some generic effects of a class of drugs on
the polymerization-depolymerization dynamics of micro-
tubules in the absence of GTP and GDP. The class of
generic drugs under consideration suppress catastrophes;
more specifically, we assumed that (i) the microtubules
capped with drug-bound tubulins do not exhibit catas-
trophe, and (ii) the rate constant for the attachment
of a drug-bound tubulin is, in general, different from
that of a drug-free tubulin. Although the effects of real
catastrophe-suppressing drugs are known [26] to be more
complicated than those of the generic model assumed
here, some predictions of the model are in good quali-
tative agreement with the corresponding effects of vin-
blastine over a limited parameter regime.
One of the two models, namely, the Hill-like model
proposed here is an extension of the model devel-
oped by Hill [9] to describe microtubule polymerization-
depolymerization dynamics in the absence of drugs. Al-
though mathematical treatment of this model is quite
simple, it does not take explicitly account for the dynam-
ics of the tubulin concentration in the solution. There-
fore, we have also developed a more detailed model in
which the effects of the concentration of the pure (i.e.,
drug-free) tubulin subunits are taken into account in our
model in a manner similar to that done by Freed [20] in
his recent theoretical study of the microtubule dynamics
in the absence of drugs. However, in this model the ef-
fects of the tubulin subunits bound to the drug molecules
could not be taken into account in a similar manner.
The reason for the difficulty in treating the concen-
trations of the drug-free and drug-bound tubulins in so-
lution on an equal footing is generic to the Hill-Freed
approach. In order that the dynamical equation for the
concentration of drug-bound tubulin subunits can reach
a steady-state, we have to allow both attachment as well
as detachment of the drug-bound subunits to the micro-
tubule. However, if shrinking of a microtubule tipped
with drug-bound tubulin is allowed, then, immediately
after such a detachment, one needs to know the status of
the subunit at the newly exposed tip, i.e., whether the
tip consists of a drug-free tubulin or a drug-bound tubu-
lin. But, in the Hill-Freed approach, the system does
not have a memory of the past history in the sense that
the the model does not keep a record of the status (i.e.,
whether or not bound to a drug molecule) of all the tubu-
lin subunits, starting from the nucleation center up to the
tip.
Therefore, in order to overcome this technical diffi-
culty, we have incorporated the effects of the drug-bound
tubulin subunits in a manner similar to the approach fol-
lowed in the Hill model [9]. Thus, our second model may
be regarded as a hybrid of the Hill-like and Freed-like
modeling strategies for the concentrations of the tubulin
subunits.
For both the Hill-like model and the Hill-Freed-like
hybrid model we have derived exact analytical expres-
sions for the steady-state probability distributions of the
lengths of microtubules tipped with drug-bound tubu-
lin subunits as well as those of microtubules tipped with
pure (i.e., drug-free) tubulin subunits in the growing and
shrinking phases. We have also compared the trends of
variations of some of the relevant quantities with the vari-
ation of the dosage of the catastrophe-suppressing drug.
We have carried out linear stability analysis of the
steady-states and established that in both the models
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the length distributions of the microtubules remain sta-
ble unless pc becomes sufficiently high to destabilize the
steady-state.
APPENDIX A: ON THE USE OF CHEBYSHEV
POLYNOMIAL
It is straight forward to see that
a′ + c′ + b′d′ = 1 +
pFg ρ(p
F
d + p
F
−+)
pFd (p
F
g ρ+ p
F
+−)
= 1 + a′c′ (A1)
Therefore, re-expressing λ′ as
λ′ =
1 + a′c′
2(a′c′)1/2
=
1
2
[{
(a′c′)1/4−(a′c′)−1/4
}2
+2
]
(A2)
we find, in general, λ′ > 1.
APPENDIX B: STEADY-STATE SOLUTIONS OF
HILL-LIKE MODEL WITH DRUGS
Here we obtain the steady-state solutions of the equa-
tions (41)-(46) for Hill-like model in the presence of drugs
by equating the RHS of these equations to zero. The solu-
tion for P−(1) is obtained by demanding dP (0, t)/dt = 0.
This leads to
P−(1) =
(pg + pc)
pd
P (0) = yP (0) (B1)
where y is given by the equation (52). Similarly, claiming
dP+(1, t)/dt = 0 and dΠ(1, t)/dt = 0, we have
P+(1) =
[pgpd + p−+(pg + pc)]
pd(pg + pc + p+−)
P (0) = xP (0)(B2)
Π(1) =
pc
pc + pg
P (0) = zP (0). (B3)
where x and z are given by the equations (51) and (53),
respectively. The special case corresponding to n = 1 of
the equation dP(n, t)/dt = 0, leads to the steady state
solution for P−(2),
P−(2) =
1
pd
[(pd + p−+)y − p+−x]P (0). (B4)
(B5)
A little bit of algebraic manipulqation leads to
P−(2) = y(x+ z)P (0). (B6)
Steady-state solutions for P+(2) and Π(2) can be ob-
tained in a similar way. Steady-state solutions for P−(n),
P+(n) and Π(n), for arbitrary n, are straightforward gen-
eralizations of our observations upto n = 4.
Since P+(n), P−(n) and Π(n) are probabilities of find-
ing microtubules of n subunits in growing, shrinking and
in catastrophe-arrested phase, we expect the following
normalization condition
P (0) +
∞∑
n=1
(P+(n) + P−(n) + Π(n)) = 1. (B7)
This leads to the form (50) for P (0).
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